A Privately Held Canadian Company.

Proteocyte receives support from organizations and individuals that believe Straticyte™ provides critical information to patients and healthcare professionals resulting in improved patient outcomes and reduced healthcare costs.

We are always seeking investment opportunities. If you share our passion to improve the health and treatment for patients with oral cancer, as either a partner or investor, please contact John Jordan at [email protected].